TMC Life Sciences Berhad reported unaudited consolidated earnings results for the second quarter ended November 30, 2013. For the quarter, the company's revenue was MYR 22,664,000 against MYR 17,517,000 a year ago. Profit from operations was MYR 4,322,000 against MYR 2,657,000 a year ago. Interest income was MYR 196,000 against MYR 81,000 a year ago. Profit before tax was MYR 2,513,000 against profit before tax of MYR 827,000 a year ago. Profit from continuing operations was MYR 2,401,000 against profit from continuing operations of MYR 879,000 a year ago. Profit after taxation was MYR 2,401,000 against MYR 4,537,000 a year ago. Profit attributable to owners of the parent was MYR 2,401,000 against MYR 4,537,000 a year ago. Diluted earnings per ordinary share attributable to the owners of the parent were 0.20 sen against 0.39 a year ago.

For the six months ended November 30, 2013, the company's revenue was MYR 41,807,000 against MYR 33,919,000 a year ago. Profit from operations was MYR 5,824,000 against MYR 4,717,000 a year ago. Interest income was MYR 374,000 against MYR 152,000 a year ago. Profit before tax was MYR 2,197,000 against profit before tax of MYR 975,000 a year ago. Profit from continuing operations was MYR 2,033,000 against profit from continuing operations of MYR 993,000 a year ago. Profit after taxation was MYR 2,033,000 against MYR 7,324,000 a year ago. Profit attributable to owners of the parent was MYR 2,033,000 against MYR 7,324,000 a year ago. Diluted earnings per ordinary share attributable to the owners of the parent were 0.17 sen against 0.63 a year ago. Net cash flows from operating activities was MYR 7,382,000 against MYR 4,072,000 a year ago.